Spravato has been approved since 2019 for TRD, with its label extended the following year as a rescue therapy for adults with major depressive disorder (MDD) who were at risk of self-harm or suicide.

After hours: March 21 at 6:48:26 PM EDT Loading Chart for FORM ...

The FDA has approved Janssen’s antidepressant nasal spray Spravato, making it the first new type of depression treatment to hit the market in 30 years – although its use will be restricted to ...

After hours: March 19 at 6:19:15 PM EDT Loading Chart for DAR ...